Biomedical Occupation or Discipline – Page 14

Chinese Vaccine Biotech Ab&B Files for IPO, Drawing Attention from GSK, Merck, and Pfizer

7 months ago talkbio0Tagged Ab&B, Bio-Tech, Biotechnology, Chinese vaccine, Drug Industry, IPO, Pfizer, Pfizer/, SmithKline Beecham

Ab&B Bio-Tech, IPO, Chinese vaccine biotech, GSK, Merck, Pfizer, biotechnology, pharmaceutical industry

Neomorph Secures Third Major Collaboration with AbbVie for Molecular Glue Degraders Worth Up to $1.64 Billion

7 months ago talkbio0Tagged AbbVie, Biotechnology, Immunology, molecular glue, Neomorph, Neoplasms, pharmaceutical collaboration, Protein Degradation, Metabolic

Neomorph, AbbVie, molecular glue degraders, protein degradation, oncology, immunology, biotechnology, pharmaceutical collaboration

Biogen’s Strategic Pivot: Emphasizing External Collaborations and Diversification

7 months ago talkbio0Tagged Alzheimer 's disease, Biogen, diversification, Immunology, Nerve Degeneration, Neuroscience discipline, Research Strategy

Biogen, research strategy, external collaborations, diversification, Alzheimer’s disease, rare diseases, immunology, neuroscience, neurodegeneration

Chinese Biotechs Flock to Hong Kong IPOs for Next Growth Phase

7 months ago talkbio0Tagged Bay Area, Biotechnology, Chinese biotechs, Greater, HKEX, IPOs, Kong, listing reforms, Listings

Chinese biotechs, Hong Kong IPOs, biotechnology, pharmaceuticals, listing reforms, HKEX, Chapter 18A, biotech listings, Greater Bay Area.

Sage Therapeutics Files Lawsuit Against Biogen Following $469 Million Acquisition Offer

7 months ago talkbio0Tagged Acquisition, Biogen, Drug Industry, Neuroscience discipline

Sage Therapeutics, Biogen, lawsuit, acquisition offer, $469 million, neuroscience, pharmaceutical industry

Trump Withdraws US from World Health Organization, Sparking Concerns Over Global Health Security

7 months ago talkbio0Tagged Communicable Diseases, COVID19 (disease), Generalized, health security, Pandemics, public health medicine (field), Transplant Registry Unified Management Program, WHO, Withdraw (activity), World Health Organization

Trump, World Health Organization, WHO, withdrawal, global health security, infectious diseases, pandemics, COVID-19, public health experts.

Servier and Google Cloud Extend Partnership to Accelerate AI-Powered Drug Development

7 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, digital transformation, Drug Development, generative, Google Cloud, Pharmaceutical Research, R&D, Servier, therapeutic solutions

Servier, Google Cloud, AI, drug development, pharmaceutical research, digital transformation, R&D, generative AI, gen AI, therapeutic solutions.

Pharmaceutical CEOs Emphasize Transparency to Counter Anti-Vaccine Sentiment in the US

7 months ago talkbio0Tagged anti-vaccine, public health medicine (field), sanofi, SmithKline Beecham, Translucent, Urinary hesitation, Vaccines

Anti-vaccine movement, Transparency, GSK, Sanofi, Vaccine hesitancy, Public health

Bioptimus Secures $76M Funding to Develop Revolutionary AI Foundation Model for Biology

7 months ago talkbio0Tagged Alanine Transaminase, Aortic Valve Insufficiency, Artificial Intelligence, biology (field), Bioptimus, Cathay Innovation, Drug Industry, medical innovation, Study models

Bioptimus, AI foundation model, biology, funding, Cathay Innovation, GPT of biology, biological research, pharmaceutical industry, biotech, medical innovation.

Denali and AbbVie’s ALS Candidates Fail Phase 2/3 Trials, Highlighting Challenges in ALS Research

7 months ago talkbio0Tagged AbbVie, Amyotrophic Lateral Sclerosis, Calico Life Sciences, Clinical Trials, Denali, DNL343, Drug Development, fosigotifator, HEALEY

ALS, Denali Therapeutics, AbbVie, Calico Life Sciences, HEALEY ALS Platform Trial, DNL343, fosigotifator, amyotrophic lateral sclerosis, clinical trials, drug development